- Not Fee assured
- Awaiting verification
Trained at King's College Hospital Medical School, London, completed training in Endocrinology in London. Wellcome Trust Research Fellow at Imperial College1994-7 during which time completed MD on 'Hormonal Control of Pituitary Function'. Appointed consultant at Hammersmith Hospital, Imperial College NHS Trust-2000, Appointed Fellow of the Royal College of Physicians 2004. Senior clinician in Endocrinology at Hammersmith Hospital, active teaching commitment and Co-organizer for Graduate Entry Programme Medical course in Endocrinology at Imperial College. Specialist and research interests include MEN 1 and 2 and Neuroendocrine tumours.
Areas of interest
All aspects of endocrinology and diabetes including thyroid, adrenal, PCOS, prolactin and pituitary diseases, calcium/bone metabolism and MEN 1 and 2.
- 020 7460 5700
Current NHS consultant posts held
MEN 1 and Neuroendocrine tumours (see published papers)
1. DL Morganstein, DH Lewis, Jackson J, Isla A, Lynn J, Devendra D, Meeran K, Todd JF. The role of arterial stimulation and simultaneous venous sampling in addition to cross-sectional imaging for localization of biochemically proven insulinomas. Eur Radiol. 2009 Oct;19(10):2467-73. Epub 2009 Jul 14.
Isla AM, Arbuckle JD, Kekis PB, Lim A, Jackson JE, Todd JF, Lynn J. Laproscopic management of insulinomas Br J Surg 2009: Feb, 96(2): 185-90
Todd JF, Bloom SR. Incretins and other peptides in the treatment of type 2 diabetes. Diabetic Medicine, 2007:24 223-232.
Dhillo WS, Jeyasenna C, Jackson JE, Lynn J, Bloom SR, Meeran K, Todd JF. Localization of gastrinomas by selective intra-arterial calcium injection in patients on proton pump inhibitor or H2-receptor antagonist therapy. Eur J Gastroenterol Hepatol. 2005 Apr;17(4):429-33.
Todd JF, Stanley SA, Roufosse CA, Bishop AE, B Khoo, Bloom SR, Meeran K. A Glucagon-like peptide 1 and somatostatin secreting tumour causing reactive hypoglycaemia and diabetes Lancet 2003:361:228-230.
Affiliations / memberships
British Endocrine Society, Neuroendocrine Tumour Society UK, Royal Society of Medicine